7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The aryl hydrocarbon receptor nuclear translocator (ARNT) modulates the antioxidant response in AML cells.

      Leukemia Research
      Animals, Antioxidants, metabolism, Aryl Hydrocarbon Receptor Nuclear Translocator, physiology, Cells, Cultured, Drug Resistance, Neoplasm, genetics, Gene Expression Profiling, Gene Expression Regulation, Leukemic, HL-60 Cells, Humans, Leukemia, Myeloid, Acute, Mice, Microarray Analysis, NIH 3T3 Cells, Oxidative Stress, Reactive Oxygen Species, Stress, Physiological, U937 Cells

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We observed AML cell lines vary in their sensitivity to induction of apoptosis by troglitazone (TG), which induces apoptosis through the generation of intracellular reactive oxygen species (ROS). TG-resistant cell lines had increased abundance of ARNT transcripts and protein. Expression of ARNT in TG-sensitive cells made these cells resistant to both TG and daunorubicin. ARNT-expressing cells had increased expression of SOD2 and Nrf2 transcripts and elevated intracellular GSH concentration. Our results indicate that ARNT expression in AML cells augments antioxidant response and confers resistance to ROS inducers. This suggests ARNT may modulate ROS signaling and drug response in AML. Copyright © 2013 Elsevier Ltd. All rights reserved.

          Related collections

          Author and article information

          Comments

          Comment on this article